View Article

Abstract

Rheumatoid arthritis is a chronic inflammatory disorder associated with pain, swelling, stiffness, and joint damage. The present study aimed to formulate and evaluate a topical roll-on containing diclofenac sodium and curcumin for effective management of rheumatoid arthritis. The formulations were prepared using suitable excipients, oils, and penetration enhancers to improve topical drug delivery. Pre-formulation studies including UV spectrophotometric analysis and FT-IR spectroscopy were performed for drug identification and compatibility assessment. FT-IR studies confirmed compatibility between diclofenac sodium and curcumin without significant interaction. The prepared formulations were evaluated for physical appearance, homogeneity, pH, viscosity, spreadability, leakage test, and skin irritation test. The formulations showed satisfactory physicochemical properties, good spreadability, acceptable pH, and absence of irritation or leakage. The study concluded that the developed topical roll-on formulation may provide an effective and convenient approach for the management of rheumatoid arthritis with improved patient compliance and reduced systemic side effects.

Keywords

Rheumatoid Arthritis, Roll-On, Diclofenac Sodium, Curcumin

Introduction

× Popup Image

Rheumatoid arthritis is a chronic, progressive autoimmune inflammatory disorder that primarily affects synovial joints, leading to pain, swelling, stiffness, and eventual joint deformity1 It is associated with systemic complications and significantly impacts the quality of life and daily activities of patients2. The pathophysiology involves activation of immune responses and release of inflammatory mediators such as cytokines, prostaglandins, and enzymes that contribute to joint destruction1,20 Conventional management mainly includes non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac sodium, which provide effective symptomatic relief by inhibiting cyclooxygenase (COX) enzymes and reducing prostaglandin synthesis3. However, long-term use of NSAIDs may result in adverse effects such as gastrointestinal irritation and cardiovascular risks3,8. On the other hand, curcumin, a natural polyphenolic compound, has been widely reported for its anti-inflammatory and antioxidant properties4,18 It acts by modulating multiple signaling pathways, including inhibition of NF-κB and other inflammatory mediators?. Studies on combined formulations of diclofenac sodium and curcumin have demonstrated enhanced therapeutic effectiveness due to their complementary mechanisms of action5,7

Pathophysiology of Rheumatoid Arthritis

 

 

 

 

Fig. No. 1: Pathophysiology of Rheumatoid Arthritis

 

Topical Drug Delivery Systems -

Topical drug delivery systems have emerged as an effective alternative to conventional oral therapy, especially for localized conditions such as rheumatoid arthritis. These systems offer several advantages, including direct application at the site of inflammation, reduced systemic drug exposure, and minimized adverse effects. The effectiveness of topical delivery depends on the formulation design and the use of suitable excipients such as oils and penetration enhancers, which facilitate drug permeation through the skin?. Various studies have indicated that topical formulations containing anti-inflammatory agents can provide sustained drug release, improved bioavailability at the target site, and enhanced patient compliance?. Therefore, topical delivery systems represent a safe and efficient strategy for the treatment of inflammatory conditions.7

 

 

 

Fig. No. 2: Mechanism of Topical Drug Penetration

 

Roll-On Formulation:

Among the different topical dosage forms, roll-on formulations have gained increasing attention due to their convenience, portability, and user-friendly nature. The roll-on applicator allows uniform distribution of the formulation over the affected area without direct hand contact, thereby maintaining hygiene and reducing the risk of contamination. Studies on roll-on formulations have reported good physical stability, effective drug delivery, and high patient acceptability. Therefore, the development of a topical roll-on formulation containing diclofenac sodium and curcumin can be considered a novel and effective approach for the management of rheumatoid arthritis6,11,12

MATERIALS AND METHODS:

Diclofenac sodium was gifted from Rajgad Dnyanpeeth’s College of Pharmacy Bhor. Curcumin extract was procured from Aushadhi Herbal. Castor oil, coconut oil, sesame oil, and sunflower oil used in the formulation were cold-pressed oils obtained from Gradient Chemicals. Glycerin and Ethanol were procured from Gradient Chemicals.

All the materials used were of analytical grade and were used as received without further purification.

Other Excipients: 13,41

1. Castor Oil:

Family: Euphorbiaceae

Category: Oil base

Function: Acts as vehicle and increases viscosity

 

 

Fig. No. 3: Castor oil

2. Coconut Oil

Family: Arecaceae

Category: Emollient

Function: Moisturizes skin and improves spreadability

Property: Soothing, anti-inflammatory, skin-friendly

 

 

Fig. No. 4: Coconut oil

3.Sesame Oil

Family: Pedaliaceae

Category: Penetration enhancer

Function: Enhances drug absorption through skin

Property: Rich in antioxidants, good permeation ability

 

 

Fig. No. 5: Sesame oil

4.Sunflower Oil

Family: Asteraceae

Category: Vehicle

Function: Provides base for formulation

Property: Light, non-greasy, easily absorbable                                     

 

Fig. No. 6: Sunflower oil

5.Menthol

 Family: Lamiaceae

Category: Cooling agent

Function: Provides cooling sensation and analgesic effect

Property: Counter-irritant, soothing, refreshing

 

 

Fig. No. 7: Menthol

6.Glycerine

 Category: Humectant

 Function: Retains moisture and improves hydration

 Property: Hygroscopic, moisturizing, skin softening

 

Table No.1: Formulation of Roll-On

Sr. No.

Ingredients

F1

F2

F3

1

Diclofenac sodium

200mg

200mg

200mg

2

Curcumin

20mg

20mg

20mg

3

Menthol

100mg

200mg

300mg

4

Castor oil

0.6 ml

1.2 ml

2.0 ml

5

Coconut oil

3.6 ml

4.8 ml

5.6 ml

6

Sunflower oil

4.0 ml

6.0 ml

8.0 ml

7

Glycerin

1 ml

2 ml

3 ml

8

Ethanol

Q.S.

Q.S.

Q.S.

 

METHODS:

Accurately weighed quantity of diclofenac sodium and curcumin was taken. The oils (castor oil, coconut oil, sesame oil, and sunflower oil) were mixed together to form the oil base. Menthol was added to the oil base and mixed properly until completely dissolved. Diclofenac sodium and curcumin were then incorporated into the mixture with continuous stirring to obtain a uniform dispersion. Glycerin was added to improve consistency and smoothness of the formulation. Ethanol was added as a solvent to adjust the final volume and enhance penetration. The formulation was mixed thoroughly using mechanical shaking to ensure homogeneity. The prepared formulation was filled into roll-on bottles and stored for further evaluation.12

EVALUATION PARAMETERS: 13,14

1. Physical Appearance: The prepared formulations were visually inspected for color, clarity, and overall appearance by placing the formulations against a black and white background under normal light conditions.

2. Color and Odor: The color and odor of the prepared formulations were evaluated visually and by smelling the formulation to determine acceptability and uniformity.

3. Homogeneity: The formulations were checked for homogeneity by visual inspection to ensure uniform distribution of ingredients and absence of lumps or phase separation.

4. Texture: The texture of the formulation was evaluated by applying a small quantity on the skin surface and observing smoothness and grittiness.

5. pH: The pH of the formulation was determined using a calibrated digital pH meter. The electrode was immersed in the formulation and the pH was recorded at room temperature..

6. Viscosity: The viscosity of the formulations was measured using a Brookfield viscometer at room temperature. The Spindle no. 64 is used for determination of viscosity of roll-on. The spindle was immersed into the formulation and readings were recorded.

7. Spreadability: Spreadability was determined by applying the formulation on the skin surface and observing the ease of spreading and uniform application.

8. Leakage Test: The formulation was filled into roll-on containers and stored in upright and inverted positions. The containers were observed for any leakage over a specified period.

9. Skin Irritation Test:

A small quantity of formulation was applied on a small area of skin and observed for redness, itching, irritation, or any allergic reaction after application.

RESULTS AND DISCUSSION:

1. UV Spectrophotometric Analysis

The UV spectrum of diclofenac sodium and curcumin showed characteristic absorption peaks in the UV region. Diclofenac sodium exhibited absorption maxima at 280 nm. The observed values were found to be within the standard reported range, confirming the identity and purity of the drugs. The obtained spectra indicated suitability of the drugs for further formulation and analytical studies.

 

 

 

Fig. No.8: UV spectrum of Diclofenac Sodium

 

2. FT-IR Spectroscopic Analysis

Fourier transform infrared (FT-IR) spectra were obtained via Shimadzu IR to understand the interactions between the physical mixture of drug and excipients, which are used in the formulation of roll-on. The spectra were observed in the region from 4000 to 400 cm-1. The spectra of the pure drug (Diclofenac Sodium) and the physical mixture of drug and excipients are given in Fig. No. 9. The spectral interpretation of the drug and excipient mixture of the formulation is given in Table No. 2. Spectral analysis revealed that there was no interaction between the drug and excipients and that they were compatible with each other.

 

 

 

 

Fig. No.9 : FT-IR Graph of Diclofenac Sodium and Physical Mixture of Diclofenac Sodium with Curcumin

 

Table No.2: Interpretation of FT-IR Analysis

Sr. No.

Functional group

Std. range

(cm-1)

Observed Peak

(cm-1)

  1.  

N-H

3500-3300

3400

  1.  

C-H

3000-2850

2920

  1.  

C=O

1700-1500

1580

  1.  

O-H

3500-3200

3330

  1.  

C-Cl

800-600

750

 

  1. Physical Appearance:

The prepared formulations were visually inspected for color, clarity, and overall appearance. All formulations showed uniform appearance.

  1. Color and Odor:

The formulations exhibited a characteristic yellow color due to curcumin and a pleasant odor due to menthol.

  1. Homogeneity:

The formulations were evaluated for uniform distribution of ingredients and were found to be homogeneous with no lumps.

  1.  Texture:

The texture of the formulation was assessed by applying it on the skin and was found to be smooth and non-gritty.

  1. pH:

The pH of the formulation was determined using a pH meter and was found to be within range of 5.5 to 6.5, suitable for skin application.

  1. Viscosity:

The viscosity of the formulations was evaluated using a Brookfield viscometer. F1 showed low viscosity, F2 showed moderate viscosity, and F3 showed high viscosity. F2 was found to have optimum viscosity suitable for application.

  1. Spreadability:

The formulations were tested for ease of spreading on the skin and showed good Spreadability.

  1. Leakage Test:

The formulation was filled in a roll-on container and observed for leakage. No leakage was observed.

  1. Skin Irritation Test:

The formulation was applied on a small area of skin and no irritation or redness was observed.

 

Table No.3: Evaluation Parameter of Roll-On

Sr. No.

Parameter

F1

F2

F3

1

Appearance

Clear

Clear

Slight thick

2

Color

Yellow

Yellow

Dark Yellow

3

Odor

Mild

Pleasant

Strong menthol

4

pH

5.4

5.8

6.2

5

Viscosity

low

Moderate

High

6

Spreadability

high

Good

Moderate

7

Leakage test

No leakage

No leakage

No leakage

 

CONCLUSION

The present study successfully formulated and evaluated a topical roll-on containing Diclofenac Sodium and Curcumin. Pre-formulation studies confirmed the identity and compatibility of the drugs. The prepared formulations showed satisfactory physicochemical properties including acceptable pH, good homogeneity, appropriate viscosity, easy spreadability, and absence of skin irritation or leakage. The combination of Diclofenac Sodium and Curcumin in a roll-on dosage form may provide effective topical delivery with improved patient compliance and reduced systemic side effects. Hence, the developed formulation can be considered a promising topical drug delivery system.

ACKNOWLEDGEMENT

The authors are grateful to the management and faculty of the Rajgad Dnyanpeeth’s College of Pharmacy Bhor for providing the necessary facilities and support to carry out this research work. The authors also thank all teaching and non-teaching staff members for their cooperation during the research work.

REFERENCES

  1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038.
  2. Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–1108.
  3. Grosser T, Smyth E, FitzGerald GA. Anti-inflammatory, antipyretic, and analgesic agents. In: Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 13th ed. New York: McGraw-Hill Education; 2018.
  4. Hewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. Foods. 2017; 6(10):92.
  5. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P, Chootip C, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis. Clin Interv Aging. 2014;9:451–458.
  6. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008; 26(11):1261–1268.
  7. Benson HAE. Topical and transdermal drug delivery: principles and practice. Wiley; 2012.
  8. Barry BW. Dermatological formulations: percutaneous absorption. New York: Marcel Dekker; 2002.
  9. Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010; 26(7):1715–1731.
  10. Daily JW, Yang M, Park S. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016;19(8):717–729.
  11. Pandey G, et al. Anti-inflammatory roll-on formulation and development to treat rheumatoid arthritis. Int J Pharm Sci Res. 2025; 16(2):145–152.
  12. Lingayat PA, et al. Formulation and evaluation of herbal roll-on used in headache. Int J Res Pharm Sci. 2024;15(1):55–61.
  13. Patil VM, et al. Formulation and evaluation of topical herbal gel using Brookfield viscometer. Int J Pharm Sci Res. 2019;10(4):1825–1832.
  14. Sharma D, et al. Evaluation parameters of topical formulations: a review. Int J Pharm Sci Rev Res. 2018;49(2):120–126.
  15. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1(1):109–131.
  16. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128–137.
  17. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin: the anti-inflammatory agent. Biochem Pharmacol. 2009;78(11):1571–1580.
  18. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195–218.
  19. Altman R, Bosch B, Brune K, Patrignani P, Young C. Advances in NSAID development: evolution of diclofenac products. Drugs. 2015;75(8):859–877.
  20. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Int J Tissue React. 1998;20(1):3–15.
  21. Hadgraft J. Skin, the final frontier. Int J Pharm. 2001;224(1-2):1–18.
  22. Benson HAE. Skin structure, function, and permeability. Topical and Transdermal Drug Delivery. 2012:1–22.
  23. Kumar L, Verma R. In vitro evaluation of topical gel prepared using natural polymers. Int J Drug Deliv. 2010;2(1):58–63.
  24. Jain NK. Controlled and novel drug delivery. 1st ed. CBS Publishers; 2008.
  25. Shah VP, Maibach HI. Topical drug bioavailability, bioequivalence, and penetration. Springer; 2014.
  26. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3(2):115–124.
  27. Kapoor VP. Herbal cosmetics for skin and hair care. Nat Prod Radiance. 2005;4(4):306–314.
  28. Kalia YN, Guy RH. Modeling transdermal drug release. Adv Drug Deliv Rev. 2001;48(2-3):159–172.
  29. Aulton ME, Taylor KMG. Aulton’s pharmaceutics: the design and manufacture of medicines. 5th ed. Elsevier; 2018.
  30. Allen LV, Popovich NG, Ansel HC. Ansel’s pharmaceutical dosage forms and drug delivery systems. 10th ed. Lippincott Williams & Wilkins; 2014.
  31. Remington JP. Remington: the science and practice of pharmacy. 22nd ed. Pharmaceutical Press; 2013.
  32. Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technol Today. 2000;3(9):318–326.
  33. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol. 1976;25(15):1811–1812.
  34. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric. J Altern Complement Med. 2003;9(1):161–168.
  35. Gupta R, Dixit VP. Therapeutic applications of Curcumin: a review. Indian J Tradit Knowl. 2010;9(2):315–320.
  36. Todd PA, Sorkin EM. Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties. Drugs. 1988;35(3):244–285.
  37. Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17(6):275–342.
  38. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14(2):101–114.
  39. Singh S, Jain S, Muthu MS, Tiwari S, Tilak R. Preparation and evaluation of herbal topical formulations: a review. Int J Pharm Sci Rev Res. 2011;9(2):72–80.
  40. Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd ed. Varghese Publishing House; 2009.
  41. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed.          London: Pharmaceutical Press; 2009.
  42. Allen LV. Ansel’s pharmaceutical dosage forms and drug delivery systems. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2014.
  43. Patel RP, Patel G, Baria A. Formulation and evaluation of topical drug delivery    system: a review. Int J Pharm Life Sci. 2011;2(1):45–50.
  44. Patel D, Chaudhary SA, Parmar B, Bhura N. Transdermal drug delivery system: a review. Pharm Innov J. 2012;1(4):66–75.
  45. Brown MB, Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006;13(3):175–187.

Reference

  1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038.
  2. Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–1108.
  3. Grosser T, Smyth E, FitzGerald GA. Anti-inflammatory, antipyretic, and analgesic agents. In: Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 13th ed. New York: McGraw-Hill Education; 2018.
  4. Hewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. Foods. 2017; 6(10):92.
  5. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P, Chootip C, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis. Clin Interv Aging. 2014;9:451–458.
  6. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008; 26(11):1261–1268.
  7. Benson HAE. Topical and transdermal drug delivery: principles and practice. Wiley; 2012.
  8. Barry BW. Dermatological formulations: percutaneous absorption. New York: Marcel Dekker; 2002.
  9. Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010; 26(7):1715–1731.
  10. Daily JW, Yang M, Park S. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016;19(8):717–729.
  11. Pandey G, et al. Anti-inflammatory roll-on formulation and development to treat rheumatoid arthritis. Int J Pharm Sci Res. 2025; 16(2):145–152.
  12. Lingayat PA, et al. Formulation and evaluation of herbal roll-on used in headache. Int J Res Pharm Sci. 2024;15(1):55–61.
  13. Patil VM, et al. Formulation and evaluation of topical herbal gel using Brookfield viscometer. Int J Pharm Sci Res. 2019;10(4):1825–1832.
  14. Sharma D, et al. Evaluation parameters of topical formulations: a review. Int J Pharm Sci Rev Res. 2018;49(2):120–126.
  15. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1(1):109–131.
  16. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128–137.
  17. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin: the anti-inflammatory agent. Biochem Pharmacol. 2009;78(11):1571–1580.
  18. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195–218.
  19. Altman R, Bosch B, Brune K, Patrignani P, Young C. Advances in NSAID development: evolution of diclofenac products. Drugs. 2015;75(8):859–877.
  20. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Int J Tissue React. 1998;20(1):3–15.
  21. Hadgraft J. Skin, the final frontier. Int J Pharm. 2001;224(1-2):1–18.
  22. Benson HAE. Skin structure, function, and permeability. Topical and Transdermal Drug Delivery. 2012:1–22.
  23. Kumar L, Verma R. In vitro evaluation of topical gel prepared using natural polymers. Int J Drug Deliv. 2010;2(1):58–63.
  24. Jain NK. Controlled and novel drug delivery. 1st ed. CBS Publishers; 2008.
  25. Shah VP, Maibach HI. Topical drug bioavailability, bioequivalence, and penetration. Springer; 2014.
  26. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3(2):115–124.
  27. Kapoor VP. Herbal cosmetics for skin and hair care. Nat Prod Radiance. 2005;4(4):306–314.
  28. Kalia YN, Guy RH. Modeling transdermal drug release. Adv Drug Deliv Rev. 2001;48(2-3):159–172.
  29. Aulton ME, Taylor KMG. Aulton’s pharmaceutics: the design and manufacture of medicines. 5th ed. Elsevier; 2018.
  30. Allen LV, Popovich NG, Ansel HC. Ansel’s pharmaceutical dosage forms and drug delivery systems. 10th ed. Lippincott Williams & Wilkins; 2014.
  31. Remington JP. Remington: the science and practice of pharmacy. 22nd ed. Pharmaceutical Press; 2013.
  32. Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technol Today. 2000;3(9):318–326.
  33. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol. 1976;25(15):1811–1812.
  34. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric. J Altern Complement Med. 2003;9(1):161–168.
  35. Gupta R, Dixit VP. Therapeutic applications of Curcumin: a review. Indian J Tradit Knowl. 2010;9(2):315–320.
  36. Todd PA, Sorkin EM. Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties. Drugs. 1988;35(3):244–285.
  37. Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17(6):275–342.
  38. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14(2):101–114.
  39. Singh S, Jain S, Muthu MS, Tiwari S, Tilak R. Preparation and evaluation of herbal topical formulations: a review. Int J Pharm Sci Rev Res. 2011;9(2):72–80.
  40. Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd ed. Varghese Publishing House; 2009.
  41. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed.          London: Pharmaceutical Press; 2009.
  42. Allen LV. Ansel’s pharmaceutical dosage forms and drug delivery systems. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2014.
  43. Patel RP, Patel G, Baria A. Formulation and evaluation of topical drug delivery    system: a review. Int J Pharm Life Sci. 2011;2(1):45–50.
  44. Patel D, Chaudhary SA, Parmar B, Bhura N. Transdermal drug delivery system: a review. Pharm Innov J. 2012;1(4):66–75.
  45. Brown MB, Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006;13(3):175–187.

Photo
Dhanashri Shivatare
Corresponding author

Reasearch scholar, Rajgad Dnyanpeeth’s College of Pharmacy, Bhor, Pune

Photo
Sharda Sonawane
Co-author

Rajgad Dnyanpeeth’s College of Pharmacy, Bhor, Pune

Photo
Dhanashree Jarande
Co-author

Rajgad Dnyanpeeth’s College of Pharmacy, Bhor, Pune

Photo
Gayatri Solaskar
Co-author

Rajgad Dnyanpeeth’s College of Pharmacy, Bhor, Pune

Dhanashri Shivatare, Sharda Sonawane, Dhanashree Jarande, Gayatri Solaskar, Formulation and Evaluation of Pain Relief Roll-On Containing Diclofenac Sodium and Curcumin for Rheumatoid Arthritis, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 40012-4021, https://doi.org/10.5281/zenodo.20229739

More related articles
Antimicrobial Resistance as a Silent Pandemic: Eco...
Meghashree N., Manoj S. Gowda, Rakshithraj Chandan, Mohammed Bila...
Molecular and Clinical Parallels between Glioblast...
Nikhil Patil, Bhupendra Mahale, Himadri Patil, Sujata Girase, Pur...
Pharmacovigilance in the Modern Era...
Shrushti Krishnani, Rahul Patil, Hemant Nikumbh, Rakesh Vasave, V...
A Review of Analytical Methods for the Determination of Clindamycin in Pharmaceu...
Abhijit Jankar, Manthan Sutar, Lakshak Joshi, Ashish Jadhav...
AI and Machine Learning in Drug Discovery and Development:A Comprehensive Analys...
Arti Rana, Nitin Kumar, Abhishek Sharma, Simran, Kamlesh Rani, Prachi, Aditya Verma...
Flavored Oral Dispersible Films: A Comprehensive Review of Formulation Approache...
Dr. Pradeep H K, Prashanth K U, Nishmitha, Siddartha B S, Gururaj...
Related Articles
New Trends of Digital Data Storage in DNA...
Pranav Lodha, Vishal Pande, Prashant Patil...
Exploring Of Tolbutamide in The Treatment of Diabetes Mellitus...
Ankit Borkar, Jagdish Baheti , Lokesh Thote, Pranali Darro...
Antimicrobial Resistance as a Silent Pandemic: Ecological, Genetic, and One Heal...
Meghashree N., Manoj S. Gowda, Rakshithraj Chandan, Mohammed Bilal, Shivaraj D. R., Kushal C. B....
More related articles
Antimicrobial Resistance as a Silent Pandemic: Ecological, Genetic, and One Heal...
Meghashree N., Manoj S. Gowda, Rakshithraj Chandan, Mohammed Bilal, Shivaraj D. R., Kushal C. B....
Molecular and Clinical Parallels between Glioblastoma and Melanoma Subtypes: A C...
Nikhil Patil, Bhupendra Mahale, Himadri Patil, Sujata Girase, Purushottam Patil, Akshata Girase, Bha...
Pharmacovigilance in the Modern Era...
Shrushti Krishnani, Rahul Patil, Hemant Nikumbh, Rakesh Vasave, Vaibhavi Kate, Tejaswini Patil...
Antimicrobial Resistance as a Silent Pandemic: Ecological, Genetic, and One Heal...
Meghashree N., Manoj S. Gowda, Rakshithraj Chandan, Mohammed Bilal, Shivaraj D. R., Kushal C. B....
Molecular and Clinical Parallels between Glioblastoma and Melanoma Subtypes: A C...
Nikhil Patil, Bhupendra Mahale, Himadri Patil, Sujata Girase, Purushottam Patil, Akshata Girase, Bha...
Pharmacovigilance in the Modern Era...
Shrushti Krishnani, Rahul Patil, Hemant Nikumbh, Rakesh Vasave, Vaibhavi Kate, Tejaswini Patil...